BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
80 hedge funds and large institutions have $189M invested in BioSpecifics Technologies Corp. in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 26 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
3% more funds holding
Funds holding: 78 → 80 (+2)
2% more capital invested
Capital invested by funds: $185M → $189M (+$4.09M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.53M |
| 2 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$2.91M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.82M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$1.14M |
| 5 |
Renaissance Technologies
New York
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$5.54M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$2.37M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.74M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$631K |
| 5 |
SGI
Summit Global Investments
Bountiful,
Utah
|
-$616K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DA
76
Denali Advisors
San Diego,
California
| $2K | – | – | – |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| $2K | +$1.98K | +46 | New |
|
|
78
Wellington Management Group
Boston,
Massachusetts
| – | -$1.74M | -39,164 | Closed |
|
|
SGI
79
Summit Global Investments
Bountiful,
Utah
| – | -$616K | -13,900 | Closed |
|
|
STA
80
Summit Trail Advisors
New York
| – | -$234K | -7,393 | Closed |
|
81
Balyasny Asset Management
Chicago,
Illinois
| – | -$204K | -4,604 | Closed |
|
82
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$473 | +11 | New |
|
|
PA
83
Parallel Advisors
San Francisco,
California
| – | +$946 | +22 | New |
|
BSTC Hedge Fund Activity: Q2 2018 in Review
80 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2018, worth a combined $189M — up 2.2% from $185M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BSTC positions and 4 closed out — a net gain of 2 holders — while 39 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $3.53M. The largest seller was Stonepine Capital Management, cutting an estimated $5.54M.
- 80 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2018, up from 78 in Q1 2018.
- Funds reported $189M of BioSpecifics Technologies Corp. stock for Q2 2018, up 2.2% quarter-over-quarter.
- 6 funds opened new BioSpecifics Technologies Corp. positions in Q2 2018 and 4 closed out, a net change of +2 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2018 was BlackRock, an estimated $3.53M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2018 was Stonepine Capital Management, an estimated $5.54M sold.
Based on aggregated 13F filings for Q2 2018.